EPISODE · Jun 24, 2019 · 11 MIN
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM)
from Stock Day Media · host Stock Day Media
cannabinoid bioscience # discovery and commercialization # solid fiscal strategy # Clinical development programs # broad IP portfolio # reduced side effects # cannabinoid research and development # cannabis # patent # Cannaway # chewing gum Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM), joins the show to Discuss 2019 Milestones Visit https://stockdaymedia.com/ for more Interviews and the Latest Penny Stock News We are pleased to share the following Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Stock Day CEO Everett Jolly. The Stock Day staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on Stock Day Media. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO John Huemoeller of Axim Biotechnologies, Inc. (OTCQB: AXIM)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m